Yeast and yeast-like organisms: Difference between revisions

From IDWiki
(β†’β€: tidied table)
No edit summary
Line 1: Line 1:
== ''Candida'' species ==
==''Candida'' species==


=== Identification ===
===Identification===


* Any yeast that has growth on culture (blood, fluid, tissue) or seen on Gram stain gets subcultured to SAB-CG at 35ΒΊ C.
*Any yeast that has growth on culture (blood, fluid, tissue) or seen on Gram stain gets subcultured to SAB-CG at 35ΒΊ C.
** Growth rate: <7 days is rapid
**Growth rate: <7 days is rapid
** Texture
**Texture
** Colour of surface and reverse
**Colour of surface and reverse
* Do wet mount to confirm features of ''Candida''.
*Do wet mount to confirm features of ''Candida''.
* '''Microscopy''' for chlamydospores, pseudohyphae, hyphae, arthroconidia, blastoconidia formation, budding, capsules, pigmentation.
*'''Microscopy''' for chlamydospores, pseudohyphae, hyphae, arthroconidia, blastoconidia formation, budding, capsules, pigmentation.
** ''C. glabrata'' is smaller, does not produce hyphae or pseudohyphae, produces blastoconidia, and grows as creamy yeast colonies.
**''C. glabrata'' is smaller, does not produce hyphae or pseudohyphae, produces blastoconidia, and grows as creamy yeast colonies.
** Non-glabrata spp. usually exhibit single buddings and can have pseudohyphae (rarely true septate hyphae). Cannot identify species based on microscopy alone.
**Non-glabrata spp. usually exhibit single buddings and can have pseudohyphae (rarely true septate hyphae). Cannot identify species based on microscopy alone.
* '''MALDI-ToF''' (Vitek MS), which provides a species. If ''C. haemolunii'' or ''C. famata'' identified on Vitek, need to rule out ''C. auris''.
*'''MALDI-ToF''' (Vitek MS), which provides a species. If ''C. haemolunii'' or ''C. famata'' identified on Vitek, need to rule out ''C. auris''.
** If Vitek not β‰₯95% match, or identifies one of the two species above, then repeat the MALDI-ToF and set up Dalmau on cornmeal agar.
**If Vitek not β‰₯95% match, or identifies one of the two species above, then repeat the MALDI-ToF and set up Dalmau on cornmeal agar.
* '''Dalmau technique:''' growth in adverse conditions (bile oxgall and corn meal) to help identify differences between species of yeast.
*'''Dalmau technique:''' growth in adverse conditions (bile oxgall and corn meal) to help identify differences between species of yeast.
** Light inoculum of single colony in a #-sign pattern with lines 1 inch apart. Cover streaks with coverslip and tamp down gently. Incubate at room temperature 18-72 hours.
**Light inoculum of single colony in a #-sign pattern with lines 1 inch apart. Cover streaks with coverslip and tamp down gently. Incubate at room temperature 18-72 hours.
** Examine after 18-24 hours. Look for thick-walled chlamydospores (terminal refractory circles), blastoconidia morphology, and presence of pseudohyphae. Then continue incubating, examining daily.
**Examine after 18-24 hours. Look for thick-walled chlamydospores (terminal refractory circles), blastoconidia morphology, and presence of pseudohyphae. Then continue incubating, examining daily.
* Old-school enzymatic tests and assimilation assays.
*Old-school enzymatic tests and assimilation assays.
* '''Temperature tolerance test''' at 35-37ΒΊ C, 42ΒΊ C, and 45ΒΊ C
*'''Temperature tolerance test''' at 35-37ΒΊ C, 42ΒΊ C, and 45ΒΊ C
* '''Germ tube test:''' if positive, either ''C. albicans'' or ''C. dubliniensis''.
*'''Germ tube test:''' if positive, either ''C. albicans'' or ''C. dubliniensis''.


{| class="wikitable"
{| class="wikitable"
! Species
!Species
! Colony
!Colony
! Conidia
!Conidia
! Pseudohyphae
!Pseudohyphae
! Other
!Other
! Other Tests
!Other Tests
|-
|-
! ''C. albicans''
!''C. albicans''
| White to creamy, raised, pasty, smooth and soft, shiny and moist. May produce mycelial growth called β€œfeet” or β€œroots”.
|White to creamy, raised, pasty, smooth and soft, shiny and moist. May produce mycelial growth called β€œfeet” or β€œroots”.
| Blastoconidia globose to oval.
|Blastoconidia globose to oval.
| Well-developed, abundant with blastoconidia in clusters or grape-like arrangement at septa.
|Well-developed, abundant with blastoconidia in clusters or grape-like arrangement at septa.
| Chlamydospores: round, large, thick-walled, usually single and mostly terminal forming on the tip of pseudohyphae, but some may be sessile. True hyphae may be present in older cultures.
|Chlamydospores: round, large, thick-walled, usually single and mostly terminal forming on the tip of pseudohyphae, but some may be sessile. True hyphae may be present in older cultures.
| Growth at 42-45ΒΊ C.
|Growth at 42-45ΒΊ C.
|-
|-
! ''C. dubliniensis''
!''C. dubliniensis''
| Cream-coloured, glistening, waxy, usually smooth.
|Cream-coloured, glistening, waxy, usually smooth.
| Blastoconidia subspherical, identical to C. albicans.
|Blastoconidia subspherical, identical to C. albicans.
| Well-developed with blastoconidia in grape-like arrangement.
|Well-developed with blastoconidia in grape-like arrangement.
| Chlamydospores: round, large, thick-walled, usually in pairs, triplets, and clusters of 1-3 and mostly terminal. True hyphae may be present, especially in older culture.
|Chlamydospores: round, large, thick-walled, usually in pairs, triplets, and clusters of 1-3 and mostly terminal. True hyphae may be present, especially in older culture.
| Usually no growth at 42-45ΒΊ C.
|Usually no growth at 42-45ΒΊ C.
|-
|-
! ''C. glabrata''
!''C. glabrata''
| Small, white to cream-coloured, shiny, pasty, and smooth.
|Small, white to cream-coloured, shiny, pasty, and smooth.
| Terminal single budding, oval, and small. Typically arranged in dense groups.
|Terminal single budding, oval, and small. Typically arranged in dense groups.
| Absent, or rudimentary if present
|Absent, or rudimentary if present
|
|
|
|
|-
|-
! ''C. krusei''
!''C. krusei''
| Cream-coloured to tannish-white. Flat, dry, ground-glass appearance. Spreading edge with a delicate feathery periphery.
|Cream-coloured to tannish-white. Flat, dry, ground-glass appearance. Spreading edge with a delicate feathery periphery.
| Elongate, ellipsoidal to cylindrical. Cells are liberated and arranged parallel to the main axis appearing like logs on the stream.
|Elongate, ellipsoidal to cylindrical. Cells are liberated and arranged parallel to the main axis appearing like logs on the stream.
| Initially sparse, often present on prolonged incubation. Elondated and slender, with blastoconidia forming a cross-matchstick or treelike branching appearance at the septa.
|Initially sparse, often present on prolonged incubation. Elondated and slender, with blastoconidia forming a cross-matchstick or treelike branching appearance at the septa.
|
|
|
|
|-
|-
! ''C. parapsilosis''
!''C. parapsilosis''
| White to creamy, shiny, moist, slightly flat, mostly smooth or partly or entirely wrinkled.
|White to creamy, shiny, moist, slightly flat, mostly smooth or partly or entirely wrinkled.
| Ovoid, single or in small clusters.
|Ovoid, single or in small clusters.
| Usually abundant, but may be slow to grow. Crooked or curved, relatively short, branched chains of pseudohyphae with clusters of blastoconidia at or between septa. Christmas-tree-like arrangement.
|Usually abundant, but may be slow to grow. Crooked or curved, relatively short, branched chains of pseudohyphae with clusters of blastoconidia at or between septa. Christmas-tree-like arrangement.
| Occasional presence of large hyphal elements called giant cells.
|Occasional presence of large hyphal elements called giant cells.
|
|
|-
|-
! ''C. tropicalis''
!''C. tropicalis''
| Cream-coloured to semiwhite, dull, dry, soft, smooth and creamy. May be wrinkled or have a mycelial fringe near the edge. Can have feet (root mycelium) similar to C. albicans.
|Cream-coloured to semiwhite, dull, dry, soft, smooth and creamy. May be wrinkled or have a mycelial fringe near the edge. Can have feet (root mycelium) similar to C. albicans.
| Oval. Single or in small groups or short chains at or between septa of pseudohyphae.
|Oval. Single or in small groups or short chains at or between septa of pseudohyphae.
| Very active growth. Abundant, long and branched. Blastoconidia produced in verticils from the pseudohyphae.
|Very active growth. Abundant, long and branched. Blastoconidia produced in verticils from the pseudohyphae.
| True hyphae may be present.
|True hyphae may be present.
|
|
|-
|-
! ''C. famata''
!''C. famata''
| White to cream coloured.
|White to cream coloured.
| Ellipsoidal.
|Ellipsoidal.
| Absent.
|Absent.
|
|
| Weak growth at 40ΒΊ C. Does not grow at 42ΒΊ C.
|Weak growth at 40ΒΊ C. Does not grow at 42ΒΊ C.
|-
|-
! ''C. auris''
!''C. auris''
| White to cream-coloured. Pink to beige on chromogenic agar (depending on the agar).
|White to cream-coloured. Pink to beige on chromogenic agar (depending on the agar).
| Oval or elongated yeast cells, singly or in pairs or groups.
|Oval or elongated yeast cells, singly or in pairs or groups.
| Absent.
|Absent.
|
|
| Grows well at 42ΒΊ C. Variable growth at 45ΒΊ C. Cycloheximide-susceptible. Usually fluconazole-resistant.
|Grows well at 42ΒΊ C. Variable growth at 45ΒΊ C. Cycloheximide-susceptible. Usually fluconazole-resistant.
|-
|-
! ''C. guilliermondii''
!''C. guilliermondii''
| White to tan, slightly heaped, shiny, moist, and usually mucoid with smooth edge.
|White to tan, slightly heaped, shiny, moist, and usually mucoid with smooth edge.
| Spherical to ellipsoidal.
|Spherical to ellipsoidal.
| May be slow growing (up to 10 days), radiating from centre of masses of budding cells.
|May be slow growing (up to 10 days), radiating from centre of masses of budding cells.
| Pseudohyphae not produced.
|Pseudohyphae not produced.
| May grow at 42 ΒΊ C.
|May grow at 42 ΒΊ C.
|}
|}


=== Epidemiology ===
===Epidemiology===


* Refer to [https://doi.org/10.1093/cid/cis697 Cleveland et al; CID 2012 55:1352].
*Refer to [https://doi.org/10.1093/cid/cis697 Cleveland et al; CID 2012 55:1352].
* The predominant species worldwide (and in Canada) is '''''C. albicans''''', by a wide margin, followed by ''C. glabrata'', ''C. tropicalis'', and ''C. parapsilosis''.
*The predominant species worldwide (and in Canada) is '''''C. albicans''''', by a wide margin, followed by ''C. glabrata'', ''C. tropicalis'', and ''C. parapsilosis''.
* Non-''candida'' species are becoming more common, globally, over the past three decades.
*Non-''candida'' species are becoming more common, globally, over the past three decades.
** ''C. dubliniensis'' associated with HIV esophagitis.
**''C. dubliniensis'' associated with HIV esophagitis.
** ''C. lusitaniae'' can develop resistance to amphotericin.
**''C. lusitaniae'' can develop resistance to amphotericin.
** ''C. guilliermondii'' is multidrug resistant.
**''C. guilliermondii'' is multidrug resistant.
** ''C. auris'' still rare but may be emerging. It can be misidentified as other yeasts (most commonly ''C. haemulonii'', but also ''C. famata'', ''Saccharomyces cerevisiae'', and ''Rhodotorula glutinis'').
**''C. auris'' still rare but may be emerging. It can be misidentified as other yeasts (most commonly ''C. haemulonii'', but also ''C. famata'', ''Saccharomyces cerevisiae'', and ''Rhodotorula glutinis'').

[[File:media/image9.png]]

[[File:media/image7.png]]


Sources: [https://dx.doi.org/10.1016/j.jcrc.2006.10.038 Laverdiere et al. ''J Crit Care''. 2007;22(3):245–250], [https://doi.org/10.1111/1469-0691.12539 Guinea. ''Clin Microbiol Infect''. 2014;20(Suppl 6):5-10].
Sources: [https://dx.doi.org/10.1016/j.jcrc.2006.10.038 Laverdiere et al. ''J Crit Care''. 2007;22(3):245–250], [https://doi.org/10.1111/1469-0691.12539 Guinea. ''Clin Microbiol Infect''. 2014;20(Suppl 6):5-10].


== ''Cryptococcus'' species ==
==''Cryptococcus'' species==

=== Diagnosis of ''Cryptococcus'' meningitis ===


===Diagnosis of ''Cryptococcus'' meningitis===
* Microscopy:
** India ink can help identify encapsulated yeasts (50% of non-AIDS and 80% of AIDS will have CSF positive by India ink). India ink no longer done because antigen LFA way more sensitive and specific.
** GMS may help identify narrow-based budding.
* From culture:
** Christensen’s Urea: urease-positive yeast include ''Cryptococcus'', ''Trichosporon'', and ''Malassezia furfur''.
** Capsule present on India ink preparation.
** Characteristics include:
*** Colonies: Cream to tan in colour, slightly heaped, chiny, moist, and usually mucoid with smooth edge.
*** Conidia: Blastoconidia are round, budding attached to parent cells by narrow necks.
*** Pseudohyphae: absent
*** Extra tests: India ink to demonstrate capsule; urease positive.
** Other methods to presumptively identify the yeast are to perform a rapid urease test or to inoculate the yeast onto Staib’s birdseed, DOPA, or caffeic acid media (in which colonies will produce melanin and turn brown to black).
* Antigen detection (cryptococcal polysaccharide antigen)
** Latex agglutination (Sn & Sp 90%)
** ELISA (Sn & Sp 90%)
** Lateral flow assay (LFA) (Sn & Sp 95-100%); sensitivity higher in AIDS


*Microscopy:
[[File:media/image13.png|Performance characteristics of cryptococcal diagnostic assays in persons with suspected meningitis, Uganda and South Africa]]
**India ink can help identify encapsulated yeasts (50% of non-AIDS and 80% of AIDS will have CSF positive by India ink). India ink no longer done because antigen LFA way more sensitive and specific.
**GMS may help identify narrow-based budding.
*From culture:
**Christensen’s Urea: urease-positive yeast include ''Cryptococcus'', ''Trichosporon'', and ''Malassezia furfur''.
**Capsule present on India ink preparation.
**Characteristics include:
***Colonies: Cream to tan in colour, slightly heaped, chiny, moist, and usually mucoid with smooth edge.
***Conidia: Blastoconidia are round, budding attached to parent cells by narrow necks.
***Pseudohyphae: absent
***Extra tests: India ink to demonstrate capsule; urease positive.
**Other methods to presumptively identify the yeast are to perform a rapid urease test or to inoculate the yeast onto Staib’s birdseed, DOPA, or caffeic acid media (in which colonies will produce melanin and turn brown to black).
*Antigen detection (cryptococcal polysaccharide antigen)
**Latex agglutination (Sn & Sp 90%)
**ELISA (Sn & Sp 90%)
**Lateral flow assay (LFA) (Sn & Sp 95-100%); sensitivity higher in AIDS


The composite reference standard was defined as a CSF culture-positive (n = 459) or a culture-negative sample with β‰₯2 positive test results (e.g., India ink microscopy, CRAG latex, or CRAG LFA) and without an alternative etiologic explanation (n = 60). Source: [https://dx.doi.org/10.3201%2Feid2001.130906 Boulware ''et al''. ''EID''. 2014;20(1):45-53].
The composite reference standard was defined as a CSF culture-positive (n = 459) or a culture-negative sample with β‰₯2 positive test results (e.g., India ink microscopy, CRAG latex, or CRAG LFA) and without an alternative etiologic explanation (n = 60). Source: [https://dx.doi.org/10.3201%2Feid2001.130906 Boulware ''et al''. ''EID''. 2014;20(1):45-53].


=== ''Cryptococcus gattii'' and ''C. neoformans'' ===
===''Cryptococcus gattii'' and ''C. neoformans''===


=== Epidemiology of ''C. gattii'' ===
===Epidemiology of ''C. gattii''===


* Unlike ''C.neoformans, C. gattii'' has never been found from bird/bat guano. It is usually found in eucalyptus (River red and Forest red gum trees) and coniferous trees, specifically in Vancouver Island and the West Coast
*Unlike ''C.neoformans, C. gattii'' has never been found from bird/bat guano. It is usually found in eucalyptus (River red and Forest red gum trees) and coniferous trees, specifically in Vancouver Island and the West Coast
* No specific seasonality, one study reports more cases in the fall and winter
*No specific seasonality, one study reports more cases in the fall and winter
* No human-to-human transmission (unless in solid organ transplantation of an infected organ)
*No human-to-human transmission (unless in solid organ transplantation of an infected organ)
* Unlike ''C. neoformans'', ''C. gattii'' usually affects immunocompetent individuals
*Unlike ''C. neoformans'', ''C. gattii'' usually affects immunocompetent individuals
* Incubation period is 1 year
*Incubation period is 1 year
* More likely to cause cryptococcomas
*More likely to cause cryptococcomas


=== Distinguishing ''C. gattii'' and ''C. neoformans'' ===
===Distinguishing ''C. gattii'' and ''C. neoformans''===


* A color reaction on '''concanavalin-glycine-thymol''' agar
*A color reaction on '''concanavalin-glycine-thymol''' agar
** Creatinine deiminase is repressed by ammonia in ''C''. ''neoformans'' but not in ''C''. ''gattii''. This difference is manifested by a change in the color of the diagnostic media as the pH changes
**Creatinine deiminase is repressed by ammonia in ''C''. ''neoformans'' but not in ''C''. ''gattii''. This difference is manifested by a change in the color of the diagnostic media as the pH changes
** Media containing L-canavanine and glycine with bromothymol blue as the color indicator for growth (CGB medium) can efficiently differentiate between these two species (''C. gattii'' will produce a color change and ''C.neoformans'' will not)
**Media containing L-canavanine and glycine with bromothymol blue as the color indicator for growth (CGB medium) can efficiently differentiate between these two species (''C. gattii'' will produce a color change and ''C.neoformans'' will not)
* They produce different sexual spores (impractical)
*They produce different sexual spores (impractical)
* MALDI-TOF may be able to identify the different species
*MALDI-TOF may be able to identify the different species


== Other yeasts of clinical importance ==
==Other yeasts of clinical importance==


=== ''Trichosporon'' ===
===''Trichosporon''===


* Clinical Significance:
*Clinical Significance:
** Can cause Tinea blanca/White piedra which is a mycosis of the hair. Soft nodules composed of yeast cells and arthroconidia encompass the hair shaft. (Immunocompetent)
**Can cause Tinea blanca/White piedra which is a mycosis of the hair. Soft nodules composed of yeast cells and arthroconidia encompass the hair shaft. (Immunocompetent)
** Invasive human infection is most commonly due to ''Trichosporon asahii'' or, less commonly, ''T. mucoides''. This usually occurs in immunocompromised patients.
**Invasive human infection is most commonly due to ''Trichosporon asahii'' or, less commonly, ''T. mucoides''. This usually occurs in immunocompromised patients.
*** Trichosporonosis is an acute febrile illness with dissemination to deep organs with a 64% mortality rate.
***Trichosporonosis is an acute febrile illness with dissemination to deep organs with a 64% mortality rate.
*** Often hematuria and funguria given common renal involvement
***Often hematuria and funguria given common renal involvement
*** May present with multiple red papules on skin
***May present with multiple red papules on skin
* Identification:
*Identification:
** Colonies are white to cream colored, moist and soft. Become irregularly wrinkled, dry, powdery or crumb-like with age.
**Colonies are white to cream colored, moist and soft. Become irregularly wrinkled, dry, powdery or crumb-like with age.
** Blastoconidia are ovoid to ellipsoidal, 3.5-3.5-14 um, singly or in short chains but few in number
**Blastoconidia are ovoid to ellipsoidal, 3.5-3.5-14 um, singly or in short chains but few in number
** RESISTANT to cyclohexidine
**RESISTANT to cyclohexidine
** ++ True hyphae
**++ True hyphae
** Urease positive
**Urease positive
** Treatment with '''voriconazole'''
**Treatment with '''voriconazole'''


=== ''Malassezia furfur'' ===
===''Malassezia furfur''===


* Clinical Significance:
*Clinical Significance:
** Common skin colonizer
**Common skin colonizer
** Causes catheter-related sepsis, almost always in patients who are receiving parenteral lipids through a central line
**Causes catheter-related sepsis, almost always in patients who are receiving parenteral lipids through a central line
** Described in neonates in the ICU, immunocompromised adults
**Described in neonates in the ICU, immunocompromised adults
** Can present with fever, bradycardia, thrombocytopenia
**Can present with fever, bradycardia, thrombocytopenia
** M.globosa causes tinea versicolor
**M.globosa causes tinea versicolor
* Identification:
*Identification:
** Will NOT grow on routine media
**Will NOT grow on routine media
** With olive oil overlay or use of specialized media (Dixon, Leeming-Notman): colonies are smooth, cream to yellowish brown, dry with age
**With olive oil overlay or use of specialized media (Dixon, Leeming-Notman): colonies are smooth, cream to yellowish brown, dry with age
** RESISTANT to cyclohexamide
**RESISTANT to cyclohexamide
** Yeast cells are phialides with colarettes, broad based buds
**Yeast cells are phialides with colarettes, broad based buds


=== ''Saccharomyces cerevisiae'' (β€œBaker’s Yeast”) ===
===''Saccharomyces cerevisiae'' (β€œBaker’s Yeast”)===


* Clinical Significance:
*Clinical Significance:
** Considered an occasional digestive commensal organism
**Considered an occasional digestive commensal organism
** Can cause fungemia especially in patients on probiotics with central lines/catheter-related infections
**Can cause fungemia especially in patients on probiotics with central lines/catheter-related infections
** ''S. cerevisiae'' invasive infection usually seen in immunocompromised patients, while ''S. boulardii'' usually seen in immunocompetent patients
**''S. cerevisiae'' invasive infection usually seen in immunocompromised patients, while ''S. boulardii'' usually seen in immunocompetent patients
** Has been very rarely described in esophagitis
**Has been very rarely described in esophagitis
* Identification:
*Identification:
** Colonies are white to cream, smooth and glabrous
**Colonies are white to cream, smooth and glabrous
** Evidence of multilateral budding
**Evidence of multilateral budding
** Blastoconidia are globose to ellipsoidal
**Blastoconidia are globose to ellipsoidal
** Absence of hyphae
**Absence of hyphae


=== ''Rhodotorula'' ===
===''Rhodotorula''===


* Clinical Significance:
*Clinical Significance:
** Can cause fungemia usually in immunocompromised patients or patients with central lines
**Can cause fungemia usually in immunocompromised patients or patients with central lines
** The most common underlying diseases included solid and haematologic malignancies in patients who were receiving corticosteroids and cytotoxic drugs, the presence of CVC, and the use of broad-spectrum antibiotics.
**The most common underlying diseases included solid and haematologic malignancies in patients who were receiving corticosteroids and cytotoxic drugs, the presence of CVC, and the use of broad-spectrum antibiotics.
** Can also cause localized infections i.e. meningitis, SSTI, prosthetic joint, peritoneal and ocular infections
**Can also cause localized infections i.e. meningitis, SSTI, prosthetic joint, peritoneal and ocular infections
* Identification:
*Identification:
** Colonies are pink, reddish or yellow. They are either slimy or dry.
**Colonies are pink, reddish or yellow. They are either slimy or dry.
** May have rudimentary hyphae, but ballistoconidia are absent
**May have rudimentary hyphae, but ballistoconidia are absent
** Urease positive
**Urease positive


== ''Candida auris'' ==
==''Candida auris''==


* Review the paper [https://dx.doi.org/10.1128/CMR.00029-17 Clin Micro Rev January 2018 31(1).]
*Review the paper [https://dx.doi.org/10.1128/CMR.00029-17 Clin Micro Rev January 2018 31(1).]


=== Identification Methods ===
===Identification Methods===


* ''C. auris'' can often be misidentified using the usual methods, often mistaken for ''C. haemulonii''
*''C. auris'' can often be misidentified using the usual methods, often mistaken for ''C. haemulonii''
* Use chromogenic agar to differentiate between ''C. auris'' and ''C. haemulonii'' isolates using growth characteristics
*Use chromogenic agar to differentiate between ''C. auris'' and ''C. haemulonii'' isolates using growth characteristics
** ''C. auris'' forms pink-to-beige colonies on chromogenic agar
**''C. auris'' forms pink-to-beige colonies on chromogenic agar
** Grows well at 42 degrees
**Grows well at 42 degrees
** No growth in cyclohexidine
**No growth in cyclohexidine
** No hyphae or pseudohyphae
**No hyphae or pseudohyphae
* MALDI-TOF is more accurate now that it’s been added to the database
*MALDI-TOF is more accurate now that it’s been added to the database
* PCR assays are in development (likely most helpful in an outbreak setting)
*PCR assays are in development (likely most helpful in an outbreak setting)
* Sequencing
*Sequencing


=== Susceptibility Patterns ===
===Susceptibility Patterns===


* There are no antifungal clinical breakpoints
*There are no antifungal clinical breakpoints
* Demonstrated failures and resistance to: fluconazole and other azoles i.e. voriconazole, itraconazole and isavuconazole
*Demonstrated failures and resistance to: fluconazole and other azoles i.e. voriconazole, itraconazole and isavuconazole
** Resistance to azoles likely caused by the Erg11 mutation
**Resistance to azoles likely caused by the Erg11 mutation
* Variability of susceptibility to Amphotericin B
*Variability of susceptibility to Amphotericin B
* Therefore empiric therapy is suggested with echinocandins, especially Micafungin (unless it’s a CNS infection as there is no penetration)
*Therefore empiric therapy is suggested with echinocandins, especially Micafungin (unless it’s a CNS infection as there is no penetration)
* Combination therapy is being studied with Micafungin + Voriconazole
*Combination therapy is being studied with Micafungin + Voriconazole
* CNS infections: Amphotericin B + 5-flucytosine
*CNS infections: Amphotericin B + 5-flucytosine


=== Infection Control Methods ===
===Infection Control Methods===


* Chlorhexidine is active against it
*Chlorhexidine is active against it
** Decolonize patients with chlorhexidine gluconate body wash, chlorhexidine mouthwash, and chlorhexidine-impregnated pads on CVC exit sites
**Decolonize patients with chlorhexidine gluconate body wash, chlorhexidine mouthwash, and chlorhexidine-impregnated pads on CVC exit sites
** Note: ''C. auris'' can survive up to 14 days on plastic
**Note: ''C. auris'' can survive up to 14 days on plastic
* Sodium hypochlorite and hydrogen peroxide can be used for cleaning surfaces
*Sodium hypochlorite and hydrogen peroxide can be used for cleaning surfaces
** With the exception of a water-based QAC and a 1:50 dilution of sodium hypochlorite, our data demonstrate that most disinfectants used in healthcare facilities are effective (>3-log10 reduction) against ''C. auris'' ([https://doi.org/10.1017/ice.2019.1 source]).
**With the exception of a water-based QAC and a 1:50 dilution of sodium hypochlorite, our data demonstrate that most disinfectants used in healthcare facilities are effective (>3-log10 reduction) against ''C. auris'' ([https://doi.org/10.1017/ice.2019.1 source]).
* Screening (new PIDAC 2019 guidelines exist, essentially CPE risk factor screening):
*Screening (new PIDAC 2019 guidelines exist, essentially CPE risk factor screening):
** Axilla and groin screening; additional sites as directed clinically or by previously positive sites
**Axilla and groin screening; additional sites as directed clinically or by previously positive sites
** Periodic reassessment for presence of colonization at 1- to 3-mo intervals
**Periodic reassessment for presence of colonization at 1- to 3-mo intervals
** For deisolation, 2 or more assessments 1 wk apart with negative results (off antifungals)
**For deisolation, 2 or more assessments 1 wk apart with negative results (off antifungals)
* Isolation (per CDC):
*Isolation (per CDC):
** Single room with standard and contact precautions;
**Single room with standard and contact precautions;
** gown and gloves
**gown and gloves
** hand hygiene precautions
**hand hygiene precautions
* Cleaning:
*Cleaning:
** Thorough daily and terminal cleaning/disinfection using Environmental Protection Agency-registered disinfectant effective against ''C. difficile'' spores
**Thorough daily and terminal cleaning/disinfection using Environmental Protection Agency-registered disinfectant effective against ''C. difficile'' spores


== Antifungal Susceptibility Testing of Yeast ==
==Antifungal Susceptibility Testing of Yeast==


=== Patterns of resistance ===
===Patterns of resistance===


* '''''Candida'' spp:''' most species are susceptible to azoles including fluconazole, except ''C. glabrata'' (which may be dose-dependently susceptible) ''C. krusei'', and ''C. auris''. ''C. lusitaniae'' is resistant to ampho B. All are generally susceptible to echinocandins.
*'''''Candida'' spp:''' most species are susceptible to azoles including fluconazole, except ''C. glabrata'' (which may be dose-dependently susceptible) ''C. krusei'', and ''C. auris''. ''C. lusitaniae'' is resistant to ampho B. All are generally susceptible to echinocandins.
* '''''Trichosporon'':''' azoles tested appeared to be more potent than amphotericin B, and were likely fungicidal. However, [https://doi.org/10.1093/mmy/myt029 a more recent series] reports resistance to fluconazole (though continued susceptibility to other azoles).
*'''''Trichosporon'':''' azoles tested appeared to be more potent than amphotericin B, and were likely fungicidal. However, [https://doi.org/10.1093/mmy/myt029 a more recent series] reports resistance to fluconazole (though continued susceptibility to other azoles).
* '''''Saccharomyces'':''' [https://doi.org/10.1086/497832 in one review of case reports], there was ''in vitro'' resistance to ampho B and dose-dependent susceptibility to fluconazole. However, rates of clinical response were similar and other researchers have found ''in vitro'' susceptibility to amphotericin. [https://doi.org/10.1111/myc.12604 A review of 7 cases] describes successful treatment with micafungin, caspofungin, and voriconazole.
*'''''Saccharomyces'':''' [https://doi.org/10.1086/497832 in one review of case reports], there was ''in vitro'' resistance to ampho B and dose-dependent susceptibility to fluconazole. However, rates of clinical response were similar and other researchers have found ''in vitro'' susceptibility to amphotericin. [https://doi.org/10.1111/myc.12604 A review of 7 cases] describes successful treatment with micafungin, caspofungin, and voriconazole.
* '''''Cryptococcus neoformans'':''' routinely susceptible to fluconazole and amphotericin, but ''not'' to echinocandins (does not have beta-D-glucan).
*'''''Cryptococcus neoformans'':''' routinely susceptible to fluconazole and amphotericin, but ''not'' to echinocandins (does not have beta-D-glucan).


{|
{|
! Organism
!Organism
! AmB
!AmB
! Fluc
!Fluc
! Itra
!Itra
! Vori
!Vori
! Posa
!Posa
! Anidula
!Anidula
! Caspo
!Caspo
! Mica
!Mica
! Flucyt
!Flucyt
|-
|-
| ''Aspergillus'' spp.
|''Aspergillus'' spp.
| +
| +
| –
|–
| +
| +
| +
| +
Line 282: Line 276:
| +
| +
| +
| +
| –
|–
|-
|-
|  ''A. flavus''
| ''A. flavus''
| Β±
|Β±
| –
|–
| +
| +
| +
| +
Line 293: Line 287:
| +
| +
| +
| +
| –
|–
|-
|-
|  ''A. fumigatus''
| ''A. fumigatus''
| +
| +
| –
|–
| +
| +
| +
| +
Line 304: Line 298:
| +
| +
| +
| +
| –
|–
|-
|-
|  ''A. terreus''
| ''A. terreus''
| –
|–
| –
|–
| +
| +
| +
| +
Line 315: Line 309:
| +
| +
| +
| +
| –
|–
|-
|-
|  ''A. niger''
| ''A. niger''
| +
| +
| –
|–
| Β±
|Β±
| +
| +
| +
| +
Line 326: Line 320:
| +
| +
| +
| +
| –
|–
|-
|-
| ''Candida'' spp.
|''Candida'' spp.
| +
| +
| +
| +
Line 339: Line 333:
| +
| +
|-
|-
|  ''C. albicans''
| ''C. albicans''
| +
| +
| +
| +
Line 350: Line 344:
| +
| +
|-
|-
|  ''C. glabrata''
| ''C. glabrata''
| +
| +
| SDD
|SDD
| Β±
|Β±
| +
| +
| +
| +
Line 361: Line 355:
| +
| +
|-
|-
|  ''C. krusei''
| ''C. krusei''
| +
| +
| –
|–
| Β±
|Β±
| +
| +
| +
| +
Line 370: Line 364:
| +
| +
| +
| +
| Β±
|Β±
|-
|-
|  ''C. lusitaniae''
| ''C. lusitaniae''
| –
|–
| +
| +
| +
| +
Line 383: Line 377:
| +
| +
|-
|-
|  ''C. parapsilosis''
| ''C. parapsilosis''
| +
| +
| +
| +
Line 389: Line 383:
| +
| +
| +
| +
| Β±
|Β±
| Β±
|Β±
| Β±
|Β±
| +
| +
|-
|-
|  ''C. tropicalis''
| ''C. tropicalis''
| +
| +
| +
| +
Line 405: Line 399:
| +
| +
|-
|-
| ''Crypto. neoformans''
|''Crypto. neoformans''
| +
| +
| +
| +
Line 411: Line 405:
| +
| +
| +
| +
| –
|–
| –
|–
| –
|–
| +
| +
|-
|-
| ''Coccidioides'' spp.
|''Coccidioides'' spp.
| +
| +
| +
| +
Line 422: Line 416:
| +
| +
| +
| +
| Β±
|Β±
| Β±
|Β±
| Β±
|Β±
| –
|–
|-
|-
| ''Blastomyces''
|''Blastomyces''
| +
| +
| +
| +
Line 433: Line 427:
| +
| +
| +
| +
| Β±
|Β±
| Β±
|Β±
| Β±
|Β±
| –
|–
|-
|-
| ''Histoplasma'' spp.
|''Histoplasma'' spp.
| +
| +
| +
| +
Line 444: Line 438:
| +
| +
| +
| +
| Β±
|Β±
| Β±
|Β±
| Β±
|Β±
| –
|–
|-
|-
| ''Fusarium'' spp.
|''Fusarium'' spp.
| Β±
|Β±
| –
|–
| –
|–
| +
| +
| +
| +
| –
|–
| –
|–
| –
|–
| –
|–
|-
|-
| ''Saccharomyces'' spp.
|''Saccharomyces'' spp.
| Β±
|Β±
| SDD
|SDD
| SDD
|SDD
|
|
|
|
Line 471: Line 465:
|
|
|-
|-
| ''Scedosporium apiospermum''
|''Scedosporium apiospermum''
| Β±
|Β±
| –
|–
| Β±
|Β±
| +
| +
| +
| +
| –
|–
| –
|–
| –
|–
| –
|–
|-
|-
| ''Scedosporium prolificans''
|''Scedosporium prolificans''
| –
|–
| –
|–
| –
|–
| Β±
|Β±
| Β±
|Β±
| –
|–
| –
|–
| –
|–
| –
|–
|-
|-
| ''Trichosporon'' spp.
|''Trichosporon'' spp.
| Β±
|Β±
| +
| +
| +
| +
Line 504: Line 498:
|
|
|-
|-
| Zygomycetes
|Zygomycetes
| Β±
|Β±
| –
|–
| –
|–
| –
|–
| +
| +
| –
|–
| –
|–
| –
|–
| –
|–
|}
|}


Source: [https://doi.org/10.1086/504492 Dodds Ashley ''et al''. ''CID'' 2006;43(Suppl 1):S28-S39] (''Candida'' etc.), [https://doi.org/10.1086/497832 Enache-Angoulvant, ''et al''. ''CID'' 2005;41(11):1559-1568] (''Saccharomyces''), [https://doi.org/10.1128/AAC.46.4.1144-1146.2002 Paphitou AAC 2002;46(4):1144-1146] (''Trichophyton'').
Source: [https://doi.org/10.1086/504492 Dodds Ashley ''et al''. ''CID'' 2006;43(Suppl 1):S28-S39] (''Candida'' etc.), [https://doi.org/10.1086/497832 Enache-Angoulvant, ''et al''. ''CID'' 2005;41(11):1559-1568] (''Saccharomyces''), [https://doi.org/10.1128/AAC.46.4.1144-1146.2002 Paphitou AAC 2002;46(4):1144-1146] (''Trichophyton'').


=== Mechanisms of resistance ===
===Mechanisms of resistance===

* '''Azole resistance:''' triazoles inhibit C-14Ξ± demethylase (Erg11p), which is required for the synthesis of ergosterol from lanosterol. Ergosterol is required for proper cell membrane function. There are several mechanisms of resistance:
** Induction of efflux pumps: most common mechanism, with various possible pumps
** Altered or overexpressed C-14Ξ± demethylase
** Rarely, alterations in sterol synthesis pathway
* '''Echinocandin resistance:''' echinocandins inhibit synthesis of 1,3-Ξ²-d-glucan, which is the main component of the cell wall. Resistance is conferred by mutations in the FKS gene (Fks1 for all species, as well as Fks2 in ''C. glabrata'') which encodes a subunit of glucan synthase. Ser-641 or Ser-645 account for more than 90% of resistance in ''C. albicans''. ''Cryptococcus'', by comparison, does not use that pathway and therefore has inherent resistance to echinocandins.
* '''Sources:''' Lancet ID series, Mandell, [https://doi.org/10.1016/s1473-3099(02)00181-0 Sanglard and Odds. ''Lancet ID'' 2002;2(2):73-85].


*'''Azole resistance:''' triazoles inhibit C-14Ξ± demethylase (Erg11p), which is required for the synthesis of ergosterol from lanosterol. Ergosterol is required for proper cell membrane function. There are several mechanisms of resistance:
=== Susceptibility testing ===
**Induction of efflux pumps: most common mechanism, with various possible pumps
**Altered or overexpressed C-14Ξ± demethylase
**Rarely, alterations in sterol synthesis pathway
*'''Echinocandin resistance:''' echinocandins inhibit synthesis of 1,3-Ξ²-d-glucan, which is the main component of the cell wall. Resistance is conferred by mutations in the FKS gene (Fks1 for all species, as well as Fks2 in ''C. glabrata'') which encodes a subunit of glucan synthase. Ser-641 or Ser-645 account for more than 90% of resistance in ''C. albicans''. ''Cryptococcus'', by comparison, does not use that pathway and therefore has inherent resistance to echinocandins.
*'''Sources:''' Lancet ID series, Mandell, [https://doi.org/10.1016/s1473-3099(02)00181-0 Sanglard and Odds. ''Lancet ID'' 2002;2(2):73-85].


===Susceptibility testing===
* '''Sensitire plates:''' used for Candida susceptibility testing, does colorimetric testing of broth microdilution.
* Definitions
** '''Epidemiological cut-off value (ECV or ECOFF):''' the minimum MIC or MEC that separates fungi with acquired or mutational resistance and those without. They can be used to detect antimicrobial resistance in the lab, essentially discriminating wild-type from non-wild-type strains.
** '''Clinical breakpoint:''' the MIC or MEC that predicts clinical response to the antimicrobial, which is often based on the MIC distribution, PK/PD data, and clinical outcomes from trials.
** '''Wild-type strains:''' isolates with no mechanisms of acquired resistance or reduced susceptibility for the antifungal agent being evaluated.
* '''Amphotericin and ''Candida'':''' there is no clinical breakpoint for amphotericin B with Candida, so it is reported instead as an MIC. You should consult the ECV (CLSI or other) to make an educated guess at susceptibility.


*'''Sensitire plates:''' used for Candida susceptibility testing, does colorimetric testing of broth microdilution.
[[File:./media/image3.png]]
*Definitions
**'''Epidemiological cut-off value (ECV or ECOFF):''' the minimum MIC or MEC that separates fungi with acquired or mutational resistance and those without. They can be used to detect antimicrobial resistance in the lab, essentially discriminating wild-type from non-wild-type strains.
**'''Clinical breakpoint:''' the MIC or MEC that predicts clinical response to the antimicrobial, which is often based on the MIC distribution, PK/PD data, and clinical outcomes from trials.
**'''Wild-type strains:''' isolates with no mechanisms of acquired resistance or reduced susceptibility for the antifungal agent being evaluated.
*'''Amphotericin and ''Candida'':''' there is no clinical breakpoint for amphotericin B with Candida, so it is reported instead as an MIC. You should consult the ECV (CLSI or other) to make an educated guess at susceptibility.


Source: [https://doi.org/%2010.1128/JCM.02416-16 Lockhart, ''et al''. ''J Clin Microbiol'' 2017;55:1262-1268].
Source: [https://doi.org/%2010.1128/JCM.02416-16 Lockhart, ''et al''. ''J Clin Microbiol'' 2017;55:1262-1268].


* '''Species-specific breakpoints:''' (by CLSI and EUCAST) the distribution of wild-type MICs differs between species, with the previous species-independent breakpoints often very far from the ECV. Using the species-independent breakpoints, then, may not detect the development of new resistance until much later.
*'''Species-specific breakpoints:''' (by CLSI and EUCAST) the distribution of wild-type MICs differs between species, with the previous species-independent breakpoints often very far from the ECV. Using the species-independent breakpoints, then, may not detect the development of new resistance until much later.
* '''Further Reading:''' [https://dx.doi.org/10.1128%2FJCM.00937-12 Pfaller J Clin Microbiol 2012 50(9): 2846], CLSI M59 and M27, the SOP for yeast susceptibility reporting.
*'''Further Reading:''' [https://dx.doi.org/10.1128%2FJCM.00937-12 Pfaller J Clin Microbiol 2012 50(9): 2846], CLSI M59 and M27, the SOP for yeast susceptibility reporting.


[[Category:Microbiology]]
[[Category:Microbiology]]

Revision as of 12:47, 26 August 2020

Candida species

Identification

  • Any yeast that has growth on culture (blood, fluid, tissue) or seen on Gram stain gets subcultured to SAB-CG at 35ΒΊ C.
    • Growth rate: <7 days is rapid
    • Texture
    • Colour of surface and reverse
  • Do wet mount to confirm features of Candida.
  • Microscopy for chlamydospores, pseudohyphae, hyphae, arthroconidia, blastoconidia formation, budding, capsules, pigmentation.
    • C. glabrata is smaller, does not produce hyphae or pseudohyphae, produces blastoconidia, and grows as creamy yeast colonies.
    • Non-glabrata spp. usually exhibit single buddings and can have pseudohyphae (rarely true septate hyphae). Cannot identify species based on microscopy alone.
  • MALDI-ToF (Vitek MS), which provides a species. If C. haemolunii or C. famata identified on Vitek, need to rule out C. auris.
    • If Vitek not β‰₯95% match, or identifies one of the two species above, then repeat the MALDI-ToF and set up Dalmau on cornmeal agar.
  • Dalmau technique: growth in adverse conditions (bile oxgall and corn meal) to help identify differences between species of yeast.
    • Light inoculum of single colony in a #-sign pattern with lines 1 inch apart. Cover streaks with coverslip and tamp down gently. Incubate at room temperature 18-72 hours.
    • Examine after 18-24 hours. Look for thick-walled chlamydospores (terminal refractory circles), blastoconidia morphology, and presence of pseudohyphae. Then continue incubating, examining daily.
  • Old-school enzymatic tests and assimilation assays.
  • Temperature tolerance test at 35-37ΒΊ C, 42ΒΊ C, and 45ΒΊ C
  • Germ tube test: if positive, either C. albicans or C. dubliniensis.
Species Colony Conidia Pseudohyphae Other Other Tests
C. albicans White to creamy, raised, pasty, smooth and soft, shiny and moist. May produce mycelial growth called β€œfeet” or β€œroots”. Blastoconidia globose to oval. Well-developed, abundant with blastoconidia in clusters or grape-like arrangement at septa. Chlamydospores: round, large, thick-walled, usually single and mostly terminal forming on the tip of pseudohyphae, but some may be sessile. True hyphae may be present in older cultures. Growth at 42-45ΒΊ C.
C. dubliniensis Cream-coloured, glistening, waxy, usually smooth. Blastoconidia subspherical, identical to C. albicans. Well-developed with blastoconidia in grape-like arrangement. Chlamydospores: round, large, thick-walled, usually in pairs, triplets, and clusters of 1-3 and mostly terminal. True hyphae may be present, especially in older culture. Usually no growth at 42-45ΒΊ C.
C. glabrata Small, white to cream-coloured, shiny, pasty, and smooth. Terminal single budding, oval, and small. Typically arranged in dense groups. Absent, or rudimentary if present
C. krusei Cream-coloured to tannish-white. Flat, dry, ground-glass appearance. Spreading edge with a delicate feathery periphery. Elongate, ellipsoidal to cylindrical. Cells are liberated and arranged parallel to the main axis appearing like logs on the stream. Initially sparse, often present on prolonged incubation. Elondated and slender, with blastoconidia forming a cross-matchstick or treelike branching appearance at the septa.
C. parapsilosis White to creamy, shiny, moist, slightly flat, mostly smooth or partly or entirely wrinkled. Ovoid, single or in small clusters. Usually abundant, but may be slow to grow. Crooked or curved, relatively short, branched chains of pseudohyphae with clusters of blastoconidia at or between septa. Christmas-tree-like arrangement. Occasional presence of large hyphal elements called giant cells.
C. tropicalis Cream-coloured to semiwhite, dull, dry, soft, smooth and creamy. May be wrinkled or have a mycelial fringe near the edge. Can have feet (root mycelium) similar to C. albicans. Oval. Single or in small groups or short chains at or between septa of pseudohyphae. Very active growth. Abundant, long and branched. Blastoconidia produced in verticils from the pseudohyphae. True hyphae may be present.
C. famata White to cream coloured. Ellipsoidal. Absent. Weak growth at 40ΒΊ C. Does not grow at 42ΒΊ C.
C. auris White to cream-coloured. Pink to beige on chromogenic agar (depending on the agar). Oval or elongated yeast cells, singly or in pairs or groups. Absent. Grows well at 42ΒΊ C. Variable growth at 45ΒΊ C. Cycloheximide-susceptible. Usually fluconazole-resistant.
C. guilliermondii White to tan, slightly heaped, shiny, moist, and usually mucoid with smooth edge. Spherical to ellipsoidal. May be slow growing (up to 10 days), radiating from centre of masses of budding cells. Pseudohyphae not produced. May grow at 42 ΒΊ C.

Epidemiology

  • Refer to Cleveland et al; CID 2012 55:1352.
  • The predominant species worldwide (and in Canada) is C. albicans, by a wide margin, followed by C. glabrata, C. tropicalis, and C. parapsilosis.
  • Non-candida species are becoming more common, globally, over the past three decades.
    • C. dubliniensis associated with HIV esophagitis.
    • C. lusitaniae can develop resistance to amphotericin.
    • C. guilliermondii is multidrug resistant.
    • C. auris still rare but may be emerging. It can be misidentified as other yeasts (most commonly C. haemulonii, but also C. famata, Saccharomyces cerevisiae, and Rhodotorula glutinis).

Sources: Laverdiere et al. J Crit Care. 2007;22(3):245–250, Guinea. Clin Microbiol Infect. 2014;20(Suppl 6):5-10.

Cryptococcus species

Diagnosis of Cryptococcus meningitis

  • Microscopy:
    • India ink can help identify encapsulated yeasts (50% of non-AIDS and 80% of AIDS will have CSF positive by India ink). India ink no longer done because antigen LFA way more sensitive and specific.
    • GMS may help identify narrow-based budding.
  • From culture:
    • Christensen’s Urea: urease-positive yeast include Cryptococcus, Trichosporon, and Malassezia furfur.
    • Capsule present on India ink preparation.
    • Characteristics include:
      • Colonies: Cream to tan in colour, slightly heaped, chiny, moist, and usually mucoid with smooth edge.
      • Conidia: Blastoconidia are round, budding attached to parent cells by narrow necks.
      • Pseudohyphae: absent
      • Extra tests: India ink to demonstrate capsule; urease positive.
    • Other methods to presumptively identify the yeast are to perform a rapid urease test or to inoculate the yeast onto Staib’s birdseed, DOPA, or caffeic acid media (in which colonies will produce melanin and turn brown to black).
  • Antigen detection (cryptococcal polysaccharide antigen)
    • Latex agglutination (Sn & Sp 90%)
    • ELISA (Sn & Sp 90%)
    • Lateral flow assay (LFA) (Sn & Sp 95-100%); sensitivity higher in AIDS

The composite reference standard was defined as a CSF culture-positive (n = 459) or a culture-negative sample with β‰₯2 positive test results (e.g., India ink microscopy, CRAG latex, or CRAG LFA) and without an alternative etiologic explanation (n = 60). Source: Boulware et al. EID. 2014;20(1):45-53.

Cryptococcus gattii and C. neoformans

Epidemiology of C. gattii

  • Unlike C.neoformans, C. gattii has never been found from bird/bat guano. It is usually found in eucalyptus (River red and Forest red gum trees) and coniferous trees, specifically in Vancouver Island and the West Coast
  • No specific seasonality, one study reports more cases in the fall and winter
  • No human-to-human transmission (unless in solid organ transplantation of an infected organ)
  • Unlike C. neoformans, C. gattii usually affects immunocompetent individuals
  • Incubation period is 1 year
  • More likely to cause cryptococcomas

Distinguishing C. gattii and C. neoformans

  • A color reaction on concanavalin-glycine-thymol agar
    • Creatinine deiminase is repressed by ammonia in C. neoformans but not in C. gattii. This difference is manifested by a change in the color of the diagnostic media as the pH changes
    • Media containing L-canavanine and glycine with bromothymol blue as the color indicator for growth (CGB medium) can efficiently differentiate between these two species (C. gattii will produce a color change and C.neoformans will not)
  • They produce different sexual spores (impractical)
  • MALDI-TOF may be able to identify the different species

Other yeasts of clinical importance

Trichosporon

  • Clinical Significance:
    • Can cause Tinea blanca/White piedra which is a mycosis of the hair. Soft nodules composed of yeast cells and arthroconidia encompass the hair shaft. (Immunocompetent)
    • Invasive human infection is most commonly due to Trichosporon asahii or, less commonly, T. mucoides. This usually occurs in immunocompromised patients.
      • Trichosporonosis is an acute febrile illness with dissemination to deep organs with a 64% mortality rate.
      • Often hematuria and funguria given common renal involvement
      • May present with multiple red papules on skin
  • Identification:
    • Colonies are white to cream colored, moist and soft. Become irregularly wrinkled, dry, powdery or crumb-like with age.
    • Blastoconidia are ovoid to ellipsoidal, 3.5-3.5-14 um, singly or in short chains but few in number
    • RESISTANT to cyclohexidine
    • ++ True hyphae
    • Urease positive
    • Treatment with voriconazole

Malassezia furfur

  • Clinical Significance:
    • Common skin colonizer
    • Causes catheter-related sepsis, almost always in patients who are receiving parenteral lipids through a central line
    • Described in neonates in the ICU, immunocompromised adults
    • Can present with fever, bradycardia, thrombocytopenia
    • M.globosa causes tinea versicolor
  • Identification:
    • Will NOT grow on routine media
    • With olive oil overlay or use of specialized media (Dixon, Leeming-Notman): colonies are smooth, cream to yellowish brown, dry with age
    • RESISTANT to cyclohexamide
    • Yeast cells are phialides with colarettes, broad based buds

Saccharomyces cerevisiae (β€œBaker’s Yeast”)

  • Clinical Significance:
    • Considered an occasional digestive commensal organism
    • Can cause fungemia especially in patients on probiotics with central lines/catheter-related infections
    • S. cerevisiae invasive infection usually seen in immunocompromised patients, while S. boulardii usually seen in immunocompetent patients
    • Has been very rarely described in esophagitis
  • Identification:
    • Colonies are white to cream, smooth and glabrous
    • Evidence of multilateral budding
    • Blastoconidia are globose to ellipsoidal
    • Absence of hyphae

Rhodotorula

  • Clinical Significance:
    • Can cause fungemia usually in immunocompromised patients or patients with central lines
    • The most common underlying diseases included solid and haematologic malignancies in patients who were receiving corticosteroids and cytotoxic drugs, the presence of CVC, and the use of broad-spectrum antibiotics.
    • Can also cause localized infections i.e. meningitis, SSTI, prosthetic joint, peritoneal and ocular infections
  • Identification:
    • Colonies are pink, reddish or yellow. They are either slimy or dry.
    • May have rudimentary hyphae, but ballistoconidia are absent
    • Urease positive

Candida auris

Identification Methods

  • C. auris can often be misidentified using the usual methods, often mistaken for C. haemulonii
  • Use chromogenic agar to differentiate between C. auris and C. haemulonii isolates using growth characteristics
    • C. auris forms pink-to-beige colonies on chromogenic agar
    • Grows well at 42 degrees
    • No growth in cyclohexidine
    • No hyphae or pseudohyphae
  • MALDI-TOF is more accurate now that it’s been added to the database
  • PCR assays are in development (likely most helpful in an outbreak setting)
  • Sequencing

Susceptibility Patterns

  • There are no antifungal clinical breakpoints
  • Demonstrated failures and resistance to: fluconazole and other azoles i.e. voriconazole, itraconazole and isavuconazole
    • Resistance to azoles likely caused by the Erg11 mutation
  • Variability of susceptibility to Amphotericin B
  • Therefore empiric therapy is suggested with echinocandins, especially Micafungin (unless it’s a CNS infection as there is no penetration)
  • Combination therapy is being studied with Micafungin + Voriconazole
  • CNS infections: Amphotericin B + 5-flucytosine

Infection Control Methods

  • Chlorhexidine is active against it
    • Decolonize patients with chlorhexidine gluconate body wash, chlorhexidine mouthwash, and chlorhexidine-impregnated pads on CVC exit sites
    • Note: C. auris can survive up to 14 days on plastic
  • Sodium hypochlorite and hydrogen peroxide can be used for cleaning surfaces
    • With the exception of a water-based QAC and a 1:50 dilution of sodium hypochlorite, our data demonstrate that most disinfectants used in healthcare facilities are effective (>3-log10 reduction) against C. auris (source).
  • Screening (new PIDAC 2019 guidelines exist, essentially CPE risk factor screening):
    • Axilla and groin screening; additional sites as directed clinically or by previously positive sites
    • Periodic reassessment for presence of colonization at 1- to 3-mo intervals
    • For deisolation, 2 or more assessments 1 wk apart with negative results (off antifungals)
  • Isolation (per CDC):
    • Single room with standard and contact precautions;
    • gown and gloves
    • hand hygiene precautions
  • Cleaning:
    • Thorough daily and terminal cleaning/disinfection using Environmental Protection Agency-registered disinfectant effective against C. difficile spores

Antifungal Susceptibility Testing of Yeast

Patterns of resistance

  • Candida spp: most species are susceptible to azoles including fluconazole, except C. glabrata (which may be dose-dependently susceptible) C. krusei, and C. auris. C. lusitaniae is resistant to ampho B. All are generally susceptible to echinocandins.
  • Trichosporon: azoles tested appeared to be more potent than amphotericin B, and were likely fungicidal. However, a more recent series reports resistance to fluconazole (though continued susceptibility to other azoles).
  • Saccharomyces: in one review of case reports, there was in vitro resistance to ampho B and dose-dependent susceptibility to fluconazole. However, rates of clinical response were similar and other researchers have found in vitro susceptibility to amphotericin. A review of 7 cases describes successful treatment with micafungin, caspofungin, and voriconazole.
  • Cryptococcus neoformans: routinely susceptible to fluconazole and amphotericin, but not to echinocandins (does not have beta-D-glucan).
Organism AmB Fluc Itra Vori Posa Anidula Caspo Mica Flucyt
Aspergillus spp. + – + + + + + + –
 A. flavus Β± – + + + + + + –
 A. fumigatus + – + + + + + + –
 A. terreus – – + + + + + + –
 A. niger + – Β± + + + + + –
Candida spp. + + + + + + + + +
 C. albicans + + + + + + + + +
 C. glabrata + SDD Β± + + + + + +
 C. krusei + – Β± + + + + + Β±
 C. lusitaniae – + + + + + + + +
 C. parapsilosis + + + + + Β± Β± Β± +
 C. tropicalis + + + + + + + + +
Crypto. neoformans + + + + + – – – +
Coccidioides spp. + + + + + Β± Β± Β± –
Blastomyces + + + + + Β± Β± Β± –
Histoplasma spp. + + + + + Β± Β± Β± –
Fusarium spp. Β± – – + + – – – –
Saccharomyces spp. Β± SDD SDD
Scedosporium apiospermum Β± – Β± + + – – – –
Scedosporium prolificans – – – Β± Β± – – – –
Trichosporon spp. Β± + + +
Zygomycetes Β± – – – + – – – –

Source: Dodds Ashley et al. CID 2006;43(Suppl 1):S28-S39 (Candida etc.), Enache-Angoulvant, et al. CID 2005;41(11):1559-1568 (Saccharomyces), Paphitou AAC 2002;46(4):1144-1146 (Trichophyton).

Mechanisms of resistance

  • Azole resistance: triazoles inhibit C-14Ξ± demethylase (Erg11p), which is required for the synthesis of ergosterol from lanosterol. Ergosterol is required for proper cell membrane function. There are several mechanisms of resistance:
    • Induction of efflux pumps: most common mechanism, with various possible pumps
    • Altered or overexpressed C-14Ξ± demethylase
    • Rarely, alterations in sterol synthesis pathway
  • Echinocandin resistance: echinocandins inhibit synthesis of 1,3-Ξ²-d-glucan, which is the main component of the cell wall. Resistance is conferred by mutations in the FKS gene (Fks1 for all species, as well as Fks2 in C. glabrata) which encodes a subunit of glucan synthase. Ser-641 or Ser-645 account for more than 90% of resistance in C. albicans. Cryptococcus, by comparison, does not use that pathway and therefore has inherent resistance to echinocandins.
  • Sources: Lancet ID series, Mandell, Sanglard and Odds. Lancet ID 2002;2(2):73-85.

Susceptibility testing

  • Sensitire plates: used for Candida susceptibility testing, does colorimetric testing of broth microdilution.
  • Definitions
    • Epidemiological cut-off value (ECV or ECOFF): the minimum MIC or MEC that separates fungi with acquired or mutational resistance and those without. They can be used to detect antimicrobial resistance in the lab, essentially discriminating wild-type from non-wild-type strains.
    • Clinical breakpoint: the MIC or MEC that predicts clinical response to the antimicrobial, which is often based on the MIC distribution, PK/PD data, and clinical outcomes from trials.
    • Wild-type strains: isolates with no mechanisms of acquired resistance or reduced susceptibility for the antifungal agent being evaluated.
  • Amphotericin and Candida: there is no clinical breakpoint for amphotericin B with Candida, so it is reported instead as an MIC. You should consult the ECV (CLSI or other) to make an educated guess at susceptibility.

Source: Lockhart, et al. J Clin Microbiol 2017;55:1262-1268.

  • Species-specific breakpoints: (by CLSI and EUCAST) the distribution of wild-type MICs differs between species, with the previous species-independent breakpoints often very far from the ECV. Using the species-independent breakpoints, then, may not detect the development of new resistance until much later.
  • Further Reading: Pfaller J Clin Microbiol 2012 50(9): 2846, CLSI M59 and M27, the SOP for yeast susceptibility reporting.